BellRing Brands (BRBR) Q4 2024 earnings summary

Executive summary

• Fiscal 2024 net sales grew 19.8% year-over-year to $1,996.2 million, with adjusted EBITDA up 30.1% to $440.2 million, both exceeding long-term targets.

• Premier Protein achieved record highs in household penetration, market share, and distribution, maintaining its #1 position in RTD and convenient nutrition categories.

• Dymatize saw strong international growth, offsetting domestic softness, and launched a national marketing campaign.

• The convenient nutrition category grew 6% year-over-year, with RTD products up 13% and ready-to-mix growth moderating.

• The company is prepared for unconstrained shake production and is launching major advertising campaigns and new product innovations in 2025.

Financial highlights

• Q4 net sales were $555.8 million, up 17.6% year-over-year; adjusted EBITDA was $116.5 million, up 18.3%.

• Gross profit for Q4 was $205.1 million, up 32%, with gross margin rising 400 basis points to 36.9%.

• Full-year net sales were just under $2 billion, up 20%; adjusted EBITDA reached $440.2 million, up 30.1%, with a margin of 22.1%.

• Operating profit for Q4 was $112.1 million, up 44% year-over-year.

• Fiscal 2024 SG&A expenses rose to $284.6 million (14.3% of sales), reflecting higher marketing, employee, and distribution costs.

Outlook and guidance

• Fiscal 2025 net sales expected to grow 12%-16% to $2.24-$2.32 billion; adjusted EBITDA projected at $460-$490 million, up 5%-11%.

• Adjusted EBITDA margins expected to decline 130 basis points to 20.8% at midpoint, mainly due to input cost inflation and increased marketing.

• Q1 2025 net sales growth forecasted north of 20%, with Premier Protein as the main driver.

• Marketing spend to increase significantly, especially in the first half of 2025.

• Capital expenditures for fiscal 2025 projected at approximately $7 million.